These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24378765

  • 21. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH, Gallagher JC.
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [Abstract] [Full Text] [Related]

  • 22. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
    Mirkin S, Komm BS, Pan K, Chines AA.
    Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
    [Abstract] [Full Text] [Related]

  • 23. Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis.
    Bi B, Jiang Y, Shi Y, Ruan F.
    Gynecol Endocrinol; 2022 Oct; 38(10):813-821. PubMed ID: 36036169
    [Abstract] [Full Text] [Related]

  • 24. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S, Currie H, Mikkola TS, Dragon E.
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [Abstract] [Full Text] [Related]

  • 25. Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
    Pinkerton JV, Bushmakin AG, Abraham L, Cappelleri JC, Komm BS.
    Menopause; 2016 Oct; 23(10):1092-101. PubMed ID: 27404026
    [Abstract] [Full Text] [Related]

  • 26. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ, Gillespie JA.
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [Abstract] [Full Text] [Related]

  • 27. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH, Mirkin S.
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [Abstract] [Full Text] [Related]

  • 28. Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review.
    Taylor HS, Ohleth K.
    Menopause; 2012 Apr; 19(4):479-85. PubMed ID: 22278343
    [Abstract] [Full Text] [Related]

  • 29. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 30. Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
    Kagan R, Abreu P, Andrews E.
    Postgrad Med; 2018 Nov; 130(8):687-693. PubMed ID: 30280946
    [Abstract] [Full Text] [Related]

  • 31. The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trials.
    Black D, Messig M, Yu CR, Assaf AR, Komm BS, Mirkin S, Boucher M.
    Menopause; 2016 Apr; 23(4):376-82. PubMed ID: 26694733
    [Abstract] [Full Text] [Related]

  • 32. Selective estrogen modulators in menopause.
    Gambacciani M.
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [Abstract] [Full Text] [Related]

  • 33. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK, Darmasetiawan MS, Hussain RI, Burriss SW, Holinka CF, Ausmanas MK.
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [Abstract] [Full Text] [Related]

  • 34. Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study.
    Pickar JH, Lavenberg J, Pan K, Komm BS.
    Menopause; 2018 Mar; 25(3):273-285. PubMed ID: 29088019
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA, Pinkerton JV, Gass MLS, Dorin MH, Ronkin S, Pickar JH, Constantine G.
    Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
    [Abstract] [Full Text] [Related]

  • 36. Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
    Schultz NM, Morga A, Siddiqui E, Rhoten SE.
    Adv Ther; 2024 Jun; 41(6):2233-2252. PubMed ID: 38396203
    [Abstract] [Full Text] [Related]

  • 37. A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials.
    Stevenson JC, Chines A, Pan K, Ryan KA, Mirkin S.
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2329-38. PubMed ID: 25894963
    [Abstract] [Full Text] [Related]

  • 38. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
    Pinkerton JV, Stovall DW.
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
    [Abstract] [Full Text] [Related]

  • 39. Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
    Mirkin S, Komm B, Pickar JH.
    Womens Health (Lond); 2014 Mar; 10(2):135-46. PubMed ID: 24601804
    [Abstract] [Full Text] [Related]

  • 40. Hot flush frequency and severity at baseline as predictors of time to transient and stable treatment success: pooled analysis of two CE/BZA studies.
    Pinkerton JV, Bushmakin AG, Bobula J, Lavenberg J, Komm BS, Abraham L.
    Menopause; 2017 Dec; 24(12):1378-1385. PubMed ID: 28654628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.